Accendra Health, Inc.ACHNYSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+23.2%
5Y CAGR+19.4%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+23.2%/yr
vs +19.1%/yr prior
5Y CAGR
+19.4%/yr
Recent acceleration
Acceleration
+4.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.78 | +171.4% |
| 2024 | 0.29 | -17.5% |
| 2023 | 0.35 | -16.5% |
| 2022 | 0.42 | -3.6% |
| 2021 | 0.44 | +35.0% |
| 2020 | 0.32 | +52.1% |
| 2019 | 0.21 | +1.7% |
| 2018 | 0.21 | +0.7% |
| 2017 | 0.21 | -20.6% |
| 2016 | 0.26 | - |